First Time Loading...

Abcam PLC
LSE:ABC

Watchlist Manager
Abcam PLC Logo
Abcam PLC
LSE:ABC
Watchlist
Price: 1 226 GBX 11.15%
Updated: Mar 29, 2024

Intrinsic Value

ABC price has not been updated for more than 1 month. This may indicate that the stock has been delisted.

Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. [ Read More ]

There is not enough data to reliably calculate the intrinsic value of ABC.

Key Points:
ABC Intrinsic Value
Base Case
Not Available
Base Case Scenario

Fundamental Analysis

How can I assist you today?

Provide an overview
of Abcam PLC's business.

What risks and challenges
does Abcam PLC face in the near future?

Summarize the latest earnings report
of Abcam PLC.

Provide P/E
for Abcam PLC and its competitors.

Financials

Balance Sheet Decomposition
Abcam PLC

Current Assets 257.8m
Cash & Short-Term Investments 109.6m
Receivables 72.1m
Other Current Assets 76.1m
Non-Current Assets 806.9m
Long-Term Investments 3.3m
PP&E 165.7m
Intangibles 625.9m
Other Non-Current Assets 12m
Current Liabilities 203.8m
Accounts Payable 56.7m
Short-Term Debt 119.4m
Other Current Liabilities 27.7m
Non-Current Liabilities 133.3m
Long-Term Debt 96.5m
Other Non-Current Liabilities 36.8m
Efficiency

Earnings Waterfall
Abcam PLC

Revenue
350.4m GBP
Cost of Revenue
-95.7m GBP
Gross Profit
254.7m GBP
Operating Expenses
-224.2m GBP
Operating Income
30.5m GBP
Other Expenses
-23.7m GBP
Net Income
6.8m GBP

Free Cash Flow Analysis
Abcam PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

ABC Profitability Score
Profitability Due Diligence

Abcam PLC's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

55/100
Profitability
Score

Abcam PLC's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

ABC Solvency Score
Solvency Due Diligence

Abcam PLC's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
64/100
Solvency
Score

Abcam PLC's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABC Price Targets Summary
Abcam PLC

Wall Street analysts forecast ABC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABC is 1 560.29 GBX .

Lowest
Price Target
Not Available
Average
Price Target
1 560.29 GBX
27% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

ABC Price
Abcam PLC

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
-13%
5Y 5Y
+9%
10Y 10Y
+240%
Annual Price Range
1 226
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return 16.31%
Standard Deviation of Annual Returns 6.68%
Max Drawdown -40%
Shares Statistics
Market Capitalization 2.8B GBX
Shares Outstanding 228 654 500
Percentage of Shares Shorted
N/A

ABC Return Decomposition
Main factors of price return

What is price return decomposition?

ABC News

Last Important Events
Abcam PLC

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Abcam PLC

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Abcam PLC Logo
Abcam PLC

Country

United Kingdom

Industry

Biotechnology

Market Cap

2.8B GBP

Dividend Yield

0%

Description

Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. The company is headquartered in Cambridge, Cambridgeshire and currently employs 1,750 full-time employees. The company went IPO on 2005-11-03. The firm is focused on identifying, developing and distributing reagents and tools which are required in the fields of life science research. The firm's product offering includes portfolio of antibodies and related protein research tools that are fundamental to its customers' research and experimental workflow. The firm's product type includes primary antibodies, secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selector, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers. The firm's products are used by researchers to study biological pathways, which is critical for scientific research, diagnostics and drug discovery. The firm serves scientists and researchers in academic institutions, research institutes and pharmaceutical, biotechnology and diagnostics companies.

Contact

CAMBRIDGESHIRE
Cambridge
Discovery Drive, Cambridge Biomedical Campus, Hills Road
+441223696000.0
http://www.abcam.com/

IPO

2005-11-03

Employees

1 750

Officers

CEO, Pres & Chairperson
Dr. Carl L.G. Hansen Ph.D.
Chief Financial Officer
Mr. Andrew Booth M.B.A.
COO & Director
Dr. Veronique Lecault Ph.D.
Chief Legal Officer, Chief Compliance Officer & Corp. Sec.
Mr. Tryn T. Stimart Esq., J.D.
Chief Technology Officer
Dr. Ester Falconer Ph.D.
Scientific Director
Mr. Bo Barnhart Ph.D.
Show More
VP of Communications
Ms. Tiffany Chiu B.Sc., Ph.D.
VP of Corp. Devel.
Mr. Murray McCutcheon Ph.D.
Mang. of Marketing & Communications
Alexandra Weirich M.Sc.
Sr. Mang. of People & Culture
Caitlin Webster CIPD, M.Sc.
Show Less

See Also

Discover More